Photo Credit: Olivier Fitoussi / Flash 90
Magen David Adom medical team member wearing protective gear, is handling a COVID-19 coronavirus test from a patient in Jerusalem, on April 17, 2020.

The US government has signed a $1.95 billion deal with Pfizer and its German partner BioNTech pharmaceutical firms for 100 million doses of their experimental COVID-19 vaccine once it is approved by the Food and Drug Administration (FDA).

According to the deal, US citizens would receive the vaccine for free. An additional 500 million doses can be acquired as well, the companies said.

Advertisement



“Adding a vaccine from Pfizer and BioNTech” to the government’s Operation Warp Speed inoculation-development program “increases the odds that we will have a safe, effective vaccine as soon as the end of this year,” Health and Human Services Secretary Alex Azar said in a statement.

Pfizer and BioNTech are currently evaluating four possible COVID-19 vaccines, two of which have received Fast Track designation by the FDA, which enables the firms to move ahead with an expedited development process.

Advertisement

SHARE
Previous articleJewish Women Discuss Racism Among Frum Jews
Next articleIsrael Close to 2,000-Case Trigger Point, National Lockdown Closer
Hana Levi Julian is a Middle East news analyst with a degree in Mass Communication and Journalism from Southern Connecticut State University. A past columnist with The Jewish Press and senior editor at Arutz 7, Ms. Julian has written for Babble.com, Chabad.org and other media outlets, in addition to her years working in broadcast journalism.
Loading Facebook Comments ...